Back to Search
Start Over
Supplementary Figure 6 from Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor–Positive Breast Cancer Model
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Dosing everolimus in combination with letrozole and seribantumab causes weight loss in mice
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....4d4a315521fbae02a0774debe495b013